US 12,156,902 B2
Anti-inflammatory peptides and composition comprising the same
Sang Jae Kim, Seoul (KR); Kyung Hee Kim, Seoul (KR); Kyu-Yong Lee, Seoul (KR); Seong-Ho Koh, Seoul (KR); Hyun-Hee Park, Seoul (KR); Sung Jin Huh, Seoul (KR); Woo Jin Lee, Seoul (KR); and Bum Joon Kim, Daejeon (KR)
Assigned to GemVax & KAEL Co., Ltd., Daejeon (KR)
Filed by GemVax & KAEL Co., Ltd., Daejeon (KR)
Filed on Aug. 9, 2023, as Appl. No. 18/446,712.
Application 18/446,712 is a division of application No. 17/835,278, filed on Jun. 8, 2022, granted, now 11,857,607, issued on Jan. 2, 2024.
Application 17/835,278 is a division of application No. 17/080,653, filed on Oct. 26, 2020, granted, now 11,369,665, issued on Jun. 28, 2022.
Application 17/080,653 is a division of application No. 16/025,352, filed on Jul. 2, 2018, granted, now 10,960,056, issued on Mar. 30, 2021.
Application 16/025,352 is a division of application No. 15/343,502, filed on Nov. 4, 2016, granted, now 10,039,811, issued on Aug. 7, 2018.
Application 15/343,502 is a division of application No. 14/400,291, granted, now 9,540,419, issued on Jan. 10, 2017, previously published as PCT/EP2013/059460, filed on May 7, 2013.
Claims priority of application No. 10-2012-0050529 (KR), filed on May 11, 2012; application No. 10-2012-0050533 (KR), filed on May 11, 2012; application No. 10-2012-0071989 (KR), filed on Jul. 2, 2012; application No. 10-2012-0104144 (KR), filed on Sep. 19, 2012; application No. 10-2012-0104207 (KR), filed on Sep. 19, 2012; and application No. PCT/EP2013/055329 (WO), filed on Mar. 15, 2013.
Prior Publication US 2024/0091320 A1, Mar. 21, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 38/10 (2006.01); A23L 33/18 (2016.01); A61K 8/64 (2006.01); A61K 38/00 (2006.01); A61K 38/45 (2006.01); A61P 1/02 (2006.01); A61P 19/00 (2006.01); A61P 19/04 (2006.01); A61P 19/08 (2006.01); A61P 19/10 (2006.01); A61Q 19/00 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); C12N 9/02 (2006.01)
CPC A61K 38/45 (2013.01) [A23L 33/18 (2016.08); A61K 8/64 (2013.01); A61Q 19/00 (2013.01); C07K 7/08 (2013.01); C07K 14/4703 (2013.01); C12N 9/0069 (2013.01); C12N 9/0083 (2013.01); C12Y 113/11 (2013.01); C12Y 114/99001 (2013.01); C12Y 207/07049 (2013.01); A23V 2002/00 (2013.01); A61K 38/00 (2013.01); Y02A 50/30 (2018.01)] 8 Claims
 
1. A method for treating bone, joint, muscle and connective tissue related inflammatory disease comprising administering to a subject in need thereof a composition comprising the isolated peptide of SEQ ID NO: 1
wherein the bone, joint, muscle and connective tissue related inflammatory disease is eosinophilic granuloma, arthritis, arthralgia, osteomyelitis, dermatomyositis, fasciitis, Paget's disease, gout, periodontal disease, rheumatoid arthritis, myasthenia gravis, ankylosing spondylitis, or synovitis.